\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes MissionsDue to a technical issue regarding the number of pages, the deadline for submission of all topics under call HORIZON-MISS-2025-01 (Adaptation Mission) is once again postponed.
The deadline for submission is now extended to 29 October 2025 - 17:00:00 Brussels local time.
Each newly submitted version will replace the previous one, while already submitted proposals remain valid.
This update has been published in the F&T portal for the topics to which the new deadline applies.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Digital Europe AI Continent Cybersecurity
Flanders is pursuing an active industry and export policy focused on defence innovation. With the Flemish Innovation and Industry Strategy for Security and Defence (VISD) and a new weapon trading decree, the government plans to help local companies market their technologies internationally. The European defence and security market is rapidly expan... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
